Dapagliflozin in Allo-HCT for aGVHD

Clinical trial NCT06626737 · RECRUITING

Trial details

NCT number: NCT06626737
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Graft-versus-host Disease (GVHD)

Start date: 2025-04-26
Primary completion: 2025-12-31
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.